Skip to main content
. Author manuscript; available in PMC: 2023 Jul 20.
Published in final edited form as: Head Neck. 2020 Oct 23;43(2):613–621. doi: 10.1002/hed.26510

TABLE 4.

Multivariable competing risk regression analysis of clinical factors and osteoradionecrosis

Induction chemotherapy No induction chemotherapy
Variable HR (95% CI) P HR (95% CI) P
Hypomagnesemia during treatment course
No Reference
Yes 2.72 (1.06–6.97) .037 0.93 (0.54–1.62) .81
Radiation dose 1.07 (0.95–1.20) .260 0.98 (0.91–1.06) .66
Smoking
No Reference
Yes 2.05 (0.98–4.29) .056 1.17 (0.67–2.05) .58
Tumor (T classification)a
Tx, T0 or T1 Reference
T2 1.74 (0.66–4.59) .260
T3 2.38 (0.85–6.68) .099
T4 2.78 (1.01–7.64) .047

Note: The values marked in bold italics indicate statistical significance (P < .05).

Abbreviations: CI, confidence interval; HR, hazard ratio.

a

In no induction group only.